Icecure Medical Stock Performance
| ICCM Stock | USD 0.57 0.02 3.39% |
The company retains a Market Volatility (i.e., Beta) of -0.46, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Icecure Medical are expected to decrease at a much lower rate. During the bear market, Icecure Medical is likely to outperform the market. At this point, Icecure Medical has a negative expected return of -0.28%. Please make sure to check out Icecure Medical's jensen alpha and the relationship between the potential upside and price action indicator , to decide if Icecure Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Icecure Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 10.5 M | |
| Total Cashflows From Investing Activities | 446 K |
Icecure Medical Relative Risk vs. Return Landscape
If you would invest 70.00 in Icecure Medical on November 19, 2025 and sell it today you would lose (12.63) from holding Icecure Medical or give up 18.04% of portfolio value over 90 days. Icecure Medical is currently does not generate positive expected returns and assumes 3.2036% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Icecure, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Icecure Medical Target Price Odds to finish over Current Price
The tendency of Icecure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.57 | 90 days | 0.57 | roughly 97.0 |
Based on a normal probability distribution, the odds of Icecure Medical to move above the current price in 90 days from now is roughly 97.0 (This Icecure Medical probability density function shows the probability of Icecure Stock to fall within a particular range of prices over 90 days) .
Icecure Medical Price Density |
| Price |
Predictive Modules for Icecure Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Icecure Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Icecure Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Icecure Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Icecure Medical is not an exception. The market had few large corrections towards the Icecure Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Icecure Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Icecure Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.27 | |
β | Beta against Dow Jones | -0.46 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | -0.1 |
Icecure Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Icecure Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Icecure Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Icecure Medical generated a negative expected return over the last 90 days | |
| Icecure Medical has some characteristics of a very speculative penny stock | |
| Icecure Medical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 3.29 M. Net Loss for the year was (15.32 M) with profit before overhead, payroll, taxes, and interest of 1.04 M. | |
| Icecure Medical currently holds about 17.73 M in cash with (12.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Icecure Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 40.0% of the company shares are held by company insiders |
Icecure Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Icecure Stock often depends not only on the future outlook of the current and potential Icecure Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Icecure Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.9 M | |
| Cash And Short Term Investments | 7.6 M |
Icecure Medical Fundamentals Growth
Icecure Stock prices reflect investors' perceptions of the future prospects and financial health of Icecure Medical, and Icecure Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Icecure Stock performance.
| Return On Equity | -1.58 | ||||
| Return On Asset | -0.63 | ||||
| Operating Margin | (4.51) % | ||||
| Current Valuation | 30.06 M | ||||
| Shares Outstanding | 68.96 M | ||||
| Price To Book | 4.27 X | ||||
| Price To Sales | 13.21 X | ||||
| Revenue | 3.29 M | ||||
| EBITDA | (15.36 M) | ||||
| Cash And Equivalents | 17.73 M | ||||
| Cash Per Share | 0.48 X | ||||
| Total Debt | 459 K | ||||
| Debt To Equity | 0.04 % | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (12.56 M) | ||||
| Earnings Per Share | (0.25) X | ||||
| Total Asset | 12.58 M | ||||
| Retained Earnings | (105.38 M) | ||||
About Icecure Medical Performance
By examining Icecure Medical's fundamental ratios, stakeholders can obtain critical insights into Icecure Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Icecure Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation of tumors in the human body. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Icecure Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people.Things to note about Icecure Medical performance evaluation
Checking the ongoing alerts about Icecure Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Icecure Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Icecure Medical generated a negative expected return over the last 90 days | |
| Icecure Medical has some characteristics of a very speculative penny stock | |
| Icecure Medical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 3.29 M. Net Loss for the year was (15.32 M) with profit before overhead, payroll, taxes, and interest of 1.04 M. | |
| Icecure Medical currently holds about 17.73 M in cash with (12.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Icecure Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 40.0% of the company shares are held by company insiders |
- Analyzing Icecure Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Icecure Medical's stock is overvalued or undervalued compared to its peers.
- Examining Icecure Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Icecure Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Icecure Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Icecure Medical's stock. These opinions can provide insight into Icecure Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Will Health Care Equipment & Supplies sector continue expanding? Could Icecure diversify its offerings? Factors like these will boost the valuation of Icecure Medical. Market participants price Icecure higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Icecure Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Icecure Medical requires distinguishing between market price and book value, where the latter reflects Icecure's accounting equity. The concept of intrinsic value - what Icecure Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Icecure Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Icecure Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.